Bone healing in critical-size defects treated with platelet-rich plasma: a histologic and histometric study in the calvaria of diabetic rat

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 109, Issue 1, 2010, Pages 72-78

  Mariano, Ronaldo ^a   Messora, Michel ^a,b   de Morais, Adriana ^a   Nagata, Maria ^c   Furlaneto, Flávia ^c   Avelino, Cássia ^d   Paula, Fernanda ^d   Ferreira, Sabrina ^a   Pinheiro, Marcelo ^a   de Sene, João Paulo ^a  

^a Dental School   (Brazil)

^b Lavras University Center UNILAVRAS   (Brazil)

^c SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^d FEDERAL UNIVERSITY OF ALFENAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 72149090390     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2009.08.003     Document Type: Article

References (40)

1. Verhaeghe J., van Herck E., Visser W.J., Suiker A.M., Thomasett M., Einhorn T.A., et al. Bone and mineral metabolism in BB rats with long-term diabetes. Decreased bone turnover and osteoporosis. Diabetes 39 (1990) 477-482
2. Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes-a meta-analysis. Osteoporos Int 18 (2007) 427-444
3. Loder R. The influence of diabetes mellitus on the healing of closed fractures. (review). Clin Orthop Relat Res 232 (1988) 210-216
4. Macey L.R., Kana S.M., Jingushi S., Terek R.M., Borretos J., and Bolander M.E. Defects of early fracture-healing in experimental diabetes. J Bone Joint Surg Am 71 (1989) 722-733
5. Kawaguchi H., Kurokawa T., Hanada K., Hiyama I., Tamura M., Ogata E., et al. Stimulation of fracture repair by recombinant human basic fibroblast growth factor in normal and streptozotocin-diabetic rats. Endocrinology 135 (1994) 774-781
6. Lu H., Kraut D., Gerstenfeld L.C., and Graves D.T. Diabetes interferes with the bone formation by affecting the expression of transcription factors that regulate osteoblast differentiation. Endocrinology 144 (2003) 346-352
7. Tyndall W.A., Beam H.A., Zarro C., O'Connor J.P., and Lin S.S. Decreased platelet derived growth factor expression during fracture healing in diabetic animals. Clin Orthop Relat Res 408 (2003) 319-330
8. Galiano R.D., Tepper O.M., Pelo C.R., Bhatt K.A., Callaghan M., Bastidas N., et al. Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells. Am J Pathol 164 (2004) 1935-1947
9. Salata L.A., Burgos P.M., Rasmusson L., Novaes A.B., Papalexiou A.B., Dahlin C., et al. Osseointegration of oxidized and turned implants in circumferential bone defects with and without adjunctive therapies: an experimental study on BMP-2 and autogenous bone graft in the dog mandible. Int J Oral Maxillofac Surg 36 (2007) 62-71
10. Joyce M.E., Jingushi S., and Bolander M.E. Transforming growth factor-beta in the regulation of fracture repair. Orthop Clin North Am 21 (1990) 199-209
11. McCarthy T.L., Centrella M., and Canalis E. Effects of fibroblast growth factors on deoxyribonucleic acid and collagen synthesis in rat parietal bone cells. Endocrinology 125 (1989) 2118-2126
12. Noda M., and Camilliere J.J. In vivo stimulation of bone formation by transforming growth factor-beta. Endocrinology 124 (1989) 2991-2994
13. Noda M., and Vogel R. Fibroblast growth factor enhances type beta 1 transforming growth factor gene expression in osteoblast-like cells. J Cell Biol 109 (1989) 2529-2535
14. Hoshino T., Muranishi H., Saito K., Notoya K., Makino H., Nagai H., et al. Enhancement of fracture repair in rats with streptozotocin-induced diabetes by a single injection of biodegradable microcapsules containing a bone formation stimulant, TAK-778. J Biomed Mater Res 51 (2000) 299-306
15. Marx R.E., Carlson E.R., Eichstaedt R.M., Schimmele S.R., Strauss J.E., and Georgeff K.R. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85 (1998) 638-646
16. Anitua E. Plasma rich in growth factors: preliminary results of use in the preparation of sites for implants. Int J Oral Maxillofac Implants 14 (1999) 529-535
17. Man D., Plosker H., and Winland-Brown J.E. The use of autologous platelet-rich plasma (platelet gel) and autologous platelet-poor plasma (fibrin glue) in cosmetic surgery. Plast Reconstr Surg 107 (2001) 229-237
18. Lekovic V., Camargo P.M., Weinlaender M., Vasilic N., and Kenney E.B. Comparison of platelet-rich plasma, bovine porous bone mineral, and guided tissue regeneration versus platelet-rich plasma and bovine porous bone mineral in the treatment of intrabony defects: a reentry study. J Periodontol 73 (2002) 198-205
19. Hanna R., Trejo P.M., and Weltman R.L. Treatment of intrabony defects with bovine-derived xenograft alone and in combination with platelet-rich plasma: a randomized clinical trial. J Periodontol 75 (2004) 1668-1677
20. Kassolis J.D., and Reynolds M.A. Evaluation of the adjunctive benefits of platelet-rich plasma in subantral sinus augmentation. J Craniofac Surg 16 (2005) 280-287
21. Driver V.R., Hanft J., Fylling C.P., Beriou J.M., and Autologel Diabetic Foot Ulcer Study Group. A prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers. Ostomy Wound Manage 52 (2006) 68-70 72, 74 passim
22. Pietramaggiori G., Kaipainen A., Czeczuga J.M., Wagner C.T., and Orgill D.P. Freeze-dried platelet-rich plasma shows beneficial healing properties in chronic wounds. Wound Repair Regen 14 (2006) 573-580
23. Pietramaggiori G., Scherer S.S., Mathews J.C., Alperovich M., Yang H.J., Neuwalder J., et al. Healing modulation induced by freeze-dried platelet-rich plasma and micronized allogenic dermis in a diabetic wound model. Wound Repair Regen 16 (2008) 218-225
24. Yuan N.B., Wang C., Wang Y., Yu T.T., Shu S.Q., Liu M., et al. The preliminary application of autologous platelet-rich gel used to treat refractory diabetic dermal ulcer. Sichuan Da Xue Xue Bao Yi Xue Ban 38 (2007) 900-903
25. Gandhi A., Doumas C., O'Connor J.P., Parsons J.R., and Lin S.S. The effects of local platelet rich plasma delivery on diabetic fracture healing. Bone 38 (2006) 540-546
26. Messora M.R., Nagata M.J., Mariano R.C., Dornelles R.C., Bomfin S.R., Fucini S.E., et al. Bone healing in critical-size defects treated with platelet-rich plasma: a histologic and histometric study in rat calvaria. J Periodontal Res 43 (2008) 217-223
27. Messora M.R., Nagata M.J., Dornelles R.C., Bomfim S.R., and Furlaneto S.A. Bone healing in critical-size defects treated with platelet-rich plasma activated by two different methods. A histologic and histometric study in rat calvaria. J Periodontal Res 43 (2008) 723-729
28. Alkan A., Erdem E., Günhan O., and Karasu C. Histomorphometric evaluation of the effect of doxycycline on the healing of bone defects in experimental diabetes mellitus: a pilot study. J Oral Maxillofac Surg 60 (2002) 898-904
29. de Amorim F.P., Ornelas S.S., Diniz S.F., Batista A.C., and da Silva T.A. Imbalance of RANK, RANKL and OPG expression during tibial fracture repair in diabetic rats. J Mol Histol 39 (2008) 401-408
30. Marx R.E. Platelet-rich plasma (PRP): what is PRP and what is not PRP?. Implant Dent 10 (2001) 225-228
31. Marx R.E. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg 62 (2004) 489-496
32. Lekovic V., Camargo P.M., Weinlaender M., Vasilic N., and Kenney E.B. Comparison of platelet-rich plasma, bovine porous bone mineral, and guided tissue regeneration versus platelet-rich plasma and bovine porous bone mineral in the treatment of intrabony defects: a reentry study. J Periodontol 73 (2002) 198-205
33. Harten Jr. R.D., Lee F.Y., Zimmerman M.C., Hurowitz E., Arakal R., and Behrens F.F. Regional and temporal changes in the acoustic properties of fracture callus in secondary bone healing. J Orthop Res 15 (1997) 570-576
34. Herbsman H., Powers J.C., Hirschnian A., and Shaftan G.W. Retardation of fracture healing in experimental diabetes. J Surg Res 8 (1968) 424-431
35. Diliberto P.A., Gordon G.W., Yu C.L., Earp H.S., and Herman B. Platelet-derived growth factor (PDGF) alpha receptor activation modulates the calcium mobilizing activity of the PDGF beta receptor in Balb/c3T3 fibroblasts. J Biol Chem 267 (1992) 11888-11897
36. Ai-Aql Z.S., Alagl A.S., Graves D.T., Gerstenfeld L.C., and Einhorn T.A. Molecular mechanisms controlling bone formation during fracture healing and distraction osteogenesis. J Dent Res 87 (2008) 107-118
37. Kotsovilis S., Karoussis I.K., and Fourmousis I. A comprehensive and critical review of dental implant placement in diabetic animals and patients. Clin Oral Implants Res 17 (2006) 587-599
38. Weibrich G., Kleis W.K., Hafner G., Hitzler W.E., and Wagner W. Comparison of platelet, leukocyte, and growth factor levels in point-of-care platelet-enriched plasma, prepared using a modified Curasan kit, with preparations received from a local blood bank. Clin Oral Implants Res 14 (2003) 357-362
39. Wrotniak M., Bielecki T., and Gaz̈udzik T.S. Current opinion about using the platelet-rich gel in orthopaedics and trauma surgery. Ortop Traumatol Rehabil 9 (2007) 227-238
40. King H., Aubert R.E., and Herman W. Global burden of diabetes 1995-2025. Prevalence, numerical estimates and projections. Diabetes Care 21 (1998) 1414-1431